StockDuty ← Dashboard Oct 13, 2026 11:11 PM ET
SignalCorporate

FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban

FTC alleges Martin Shkreli repeatedly violated an industry ban, signaling regulatory enforcement action.

What happened: The FTC says Martin Shkreli repeatedly violated an industry ban, accusing the convicted felon of trading in dozens of pharmaceutical stocks and sharing opinions on social media. Why it matters: The FTC's accusation concerns compliance with a ban imposed on Shkreli, a figure known for past pharmaceutical pricing actions. Coverage: 10 outlets in 24h
The FTC says Martin Shkreli repeatedly violated an industry ban, accusing the convicted felon of trading in dozens of pharmaceutical stocks and sharing opinions on social media.
The FTC's accusation concerns compliance with a ban imposed on Shkreli, a figure known for past pharmaceutical pricing actions.
Sources